SPANO, Maria Carlotta
 Distribuzione geografica
Continente #
NA - Nord America 5.691
EU - Europa 4.371
AS - Asia 2.606
SA - Sud America 368
Continente sconosciuto - Info sul continente non disponibili 123
AF - Africa 57
OC - Oceania 15
Totale 13.231
Nazione #
US - Stati Uniti d'America 5.541
SE - Svezia 1.972
IT - Italia 907
SG - Singapore 834
CN - Cina 658
GB - Regno Unito 609
VN - Vietnam 289
HK - Hong Kong 286
BR - Brasile 273
DE - Germania 240
BD - Bangladesh 130
RU - Federazione Russa 124
FR - Francia 100
UA - Ucraina 80
FI - Finlandia 79
KR - Corea 68
CA - Canada 63
TR - Turchia 62
IN - India 58
MX - Messico 44
ID - Indonesia 42
NL - Olanda 42
BE - Belgio 41
AR - Argentina 32
BG - Bulgaria 30
JP - Giappone 28
IE - Irlanda 25
ES - Italia 22
PL - Polonia 21
AL - Albania 20
PK - Pakistan 19
IQ - Iraq 18
ZA - Sudafrica 18
AE - Emirati Arabi Uniti 17
EC - Ecuador 15
AU - Australia 14
CO - Colombia 13
CL - Cile 12
UZ - Uzbekistan 12
VE - Venezuela 10
MY - Malesia 9
AT - Austria 8
CZ - Repubblica Ceca 8
JM - Giamaica 8
JO - Giordania 8
PE - Perù 8
MA - Marocco 7
PH - Filippine 7
SA - Arabia Saudita 7
SI - Slovenia 7
PT - Portogallo 6
RO - Romania 6
AZ - Azerbaigian 5
CR - Costa Rica 5
DZ - Algeria 5
NP - Nepal 5
SN - Senegal 5
TN - Tunisia 5
BB - Barbados 4
BZ - Belize 4
IL - Israele 4
KE - Kenya 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NI - Nicaragua 4
OM - Oman 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
EG - Egitto 3
HN - Honduras 3
IR - Iran 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
MN - Mongolia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
RS - Serbia 3
SV - El Salvador 3
TW - Taiwan 3
BO - Bolivia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HU - Ungheria 2
KH - Cambogia 2
MK - Macedonia 2
PA - Panama 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
Totale 13.089
Città #
Stockholm 1.775
Ashburn 668
Singapore 558
Santa Clara 452
Fairfield 428
Southend 363
San Jose 320
Hong Kong 273
Chandler 238
Woodbridge 226
Ann Arbor 221
Houston 201
Hefei 198
Seattle 185
Council Bluffs 171
Wilmington 168
Cambridge 132
Beijing 125
Dearborn 119
Modena 118
Los Angeles 115
Chicago 109
Jacksonville 109
Nyköping 105
Bologna 99
London 92
New York 92
Ho Chi Minh City 89
Hanoi 87
Milan 80
Munich 64
Seoul 63
The Dalles 54
Helsinki 51
Frankfurt am Main 47
Brussels 37
Dallas 36
Buffalo 33
Lauterbourg 32
Moscow 32
Fremont 31
Izmir 31
Jakarta 31
Shanghai 31
San Diego 29
São Paulo 29
Boardman 28
Phoenix 28
Rome 28
Orem 27
Sofia 26
Dublin 25
Princeton 25
Salt Lake City 25
Columbus 22
Eugene 22
Tampa 22
Parma 20
Lancaster 19
Tokyo 19
Atlanta 18
Denver 18
Elk Grove Village 18
Florence 18
Bremen 17
Des Moines 16
Reggio Emilia 16
San Giuliano Milanese 16
Falls Church 15
Guangzhou 15
Mexico City 15
Tirana 15
Montreal 14
Nuremberg 14
Redwood City 14
Toronto 14
Warsaw 14
Amsterdam 13
Brooklyn 13
Chennai 13
Da Nang 12
Haiphong 12
Manchester 12
Turin 11
Genoa 10
Ravenna 10
Redondo Beach 10
Hillsboro 9
Naples 9
Tashkent 9
Adelaide 8
Dulles 8
Johannesburg 8
Mumbai 8
Newark 8
Ottawa 8
Portsmouth 8
Quito 8
Romola 8
Turku 8
Totale 9.373
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.234
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 492
GD2 expression in breast cancer. 440
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 439
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 435
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 431
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus 419
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 418
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 408
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 395
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 373
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM 360
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 351
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria 345
The phenotypes of microglia and macrophages during epileptogenesis 342
Detection of microparticles from human red blood cells by multiparametric flow cytometry 330
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation 324
An adoptive immuno-gene therapy approach targeting neuroblastoma. 319
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 316
Donor Cell-Derived Osteopoiesis Originates from a Self-Renewing Stem Cell with a Limited Regenerative Contribution after Transplantation 304
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 286
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors 284
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma 273
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 270
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 262
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 256
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 247
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 227
CELLULE STAMINALI: REALTA’ E PROSPETTIVE 216
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 211
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 194
Una cellula effettrice modificata per il trattamento di neoplasie esprimenti il disialonganglioside GD2 189
Abstract A17: Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study 187
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 185
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 169
Targeting pancreatic ductal adenocarcinoma & its stroma by a chemo & gene therapy strategy 156
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 144
Totale 13.231
Categoria #
all - tutte 42.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.886


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022575 0 0 0 41 33 31 66 64 66 49 149 76
2022/2023763 100 87 48 90 87 100 12 73 91 7 47 21
2023/2024474 33 26 44 43 76 41 44 60 7 17 21 62
2024/20252.138 51 43 100 167 319 342 225 109 233 100 168 281
2025/20265.751 292 145 299 495 772 195 454 154 2.114 388 257 186
2026/2027670 102 209 237 122 0 0 0 0 0 0 0 0
Totale 13.231